11 May 2021
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency
27 Apr 2021
Oxford Immunotec’s T-SPOT®Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
04 Mar 2021
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID , a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
이 사이트는 쿠키를 사용하여 귀하의 컴퓨터에 정보를 저장합니다. 본 사이트를 작동시키기 위해 필수 쿠키가 사용되며, 사용자 경험을 개선하기 위해서는 비-필수 쿠키가 사용됩니다. 쿠키 활성화 / 비활성화동의하기더 알아보기
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.